| 产品编号 |
产品名称 |
序列 |
别称 |
CAS Number |
分子式 |
分子量 |
疾病类 |
包装 |
| CS13468 |
pHLIP G1
|
序列
|
|
|
|
|
|
|
| Gly-Leu-Ala-Gly-Leu-Ala-Gly-Leu-Leu-Gly-Leu-Glu-Gly-Leu-Leu-Gly-Leu-Pro-Leu-Gly-Leu-Leu-Glu-Gly-Leu-Trp-Leu-Gly-Leu-Glu-Leu-Glu-Gly-Asn-Cys-Ala |
| CS13469 |
pHLIP G2
|
序列
|
|
|
|
|
|
|
| Ala-Cys-Gly-Leu-Ala-Gly-Leu-Ala-Gly-Leu-Leu-Gly-Leu-Glu-Gly-Leu-Leu-Gly-Leu-Pro-Leu-Gly-Leu-Leu-Glu-Gly-Leu-Trp-Leu-Gly-Leu-Glu-Leu-Glu-Gly-Asn |
| CS13608 |
CS13608
|
序列
|
|
|
|
|
|
|
| {[(DOTAGA)2-Lys]2-Lys}2-Lys-Lys(Ahx-Ahx)-NH2 |
| CS13611 |
PEG3, RM26
|
序列
|
|
|
|
1316.51 |
|
|
| PEG3-(D-Phe)-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH2 |
| CS13675 |
Additional homo Arg, Eptifibatide impurity
|
序列
|
|
|
C28H31O6S2N7 |
625.7 |
|
|
| Mpr-(Homo-Arg)-(Homo-Arg)-Gly-Asp-Trp-Pro-Cys-NH2 (Disulfide bond Mpr1/Cys8) |
| CS13676 |
Cyclic dimer, Eptifibatide impurity
|
序列
|
|
|
C86H118O22S4N30 |
2052.2 |
|
|
| Mpr-(Homo-Arg)-Gly-Asp-Trp-Pro-Cys-NH2| |S S| |S S| |Mpr-(Homo-Arg)-Gly-Asp-Trp-Pro-Cys-NH2 |
| CS13695 |
OVA (141-160)
|
序列
|
|
|
|
|
|
|
| Cys-Ala-Arg-Glu-Leu-Ile-Asn-Ser-Trp-Val-Glu-Ser-Gln-Thr-Asn-Gly-Ile-Ile-Arg-Asn |
| CS13741 |
PMAP-36 (C/S/amide-Gly)
|
序列
|
|
|
C191H336N62O39 |
4125.1 |
|
|
| Ac-Gly-Arg-Phe-Arg-Arg-Leu-Arg-Lys-Lys-Thr-Arg-Lys-Arg-Leu-Lys-Lys-Ile-Gly-Lys-Val-Leu-Lys-Trp-Ile-Pro-Pro-Ile-Val-Gly-Ser-Ile-Pro-Leu-Gly-Ser-NH2 |
| CS13742 |
PMAP-36 (CSamide-Gly) (7-35)
|
序列
|
|
|
|
|
|
|
| Ac-Arg-Lys-Lys-Thr-Arg-Lys-Arg-Leu-Lys-Lys-Ile-Gly-Lys-Val-Leu-Lys-Trp-Ile-Pro-Pro-Ile-Val-Gly-Ser-Ile-Pro-Leu-Gly-Ser-NH2 |
| CS13743 |
PMAP-36[C/S]-amide (12-35)
|
序列
|
|
|
C128H222N34O27 |
2669.3 |
|
|
| Ac-Lys-Arg-Leu-Lys-Lys-Ile-Gly-Lys-Val-Leu-Lys-Trp-Ile-Pro-Pro-Ile-Val-Gly-Ser-Ile-Pro-Leu-Gly-Ser-NH2 |
| CS13744 |
PMAP-36[C/S]-amide (16-35)
|
序列
|
|
|
C104H175N25O23 |
2143.6 |
|
|
| Ac-Lys-Ile-Gly-Lys-Val-Leu-Lys-Trp-Ile-Pro-Pro-Ile-Val-Gly-Ser-Ile-Pro-Leu-Gly-Ser-NH2 |
| CS13745 |
Tamra, PMAP-36
|
序列
|
|
|
|
|
|
|
| Tamra-Gly-Arg-Phe-Arg-Arg-Leu-Arg-Lys-Lys-Thr-Arg-Lys-Arg-Leu-Lys-Lys-Ile-Gly-Lys-Val-Leu-Lys-Trp-Ile-Pro-Pro-Ile-Val-Gly-Ser-Ile-Pro-Leu-Gly-Cys-Gly |
| CS13746 |
Tamra, PMAP-36 (7-36)
|
序列
|
|
|
C181H299N49O38S |
3801.9 |
|
|
| Tamra-Arg-Lys-Lys-Thr-Arg-Lys-Arg-Leu-Lys-Lys-Ile-Gly-Lys-Val-Leu-Lys-Trp-Ile-Pro-Pro-Ile-Val-Gly-Ser-Ile-Pro-Leu-Gly-Cys-Gly |
| CS13747 |
Tamra, PMAP-36 (12-36)
|
序列
|
|
|
C153H244N36O32S |
3132 |
|
|
| Tamra-Lys-Arg-Leu-Lys-Lys-Ile-Gly-Lys-Val-Leu-Lys-Trp-Ile-Pro-Pro-Ile-Val-Gly-Ser-Ile-Pro-Leu-Gly-Cys-Gly |
| CS13748 |
Tamra, PMAP-36 (16-36)
|
序列
|
|
|
C129H197N27O28S |
2606.3 |
|
|
| Tamra-Lys-Ile-Gly-Lys-Val-Leu-Lys-Trp-Ile-Pro-Pro-Ile-Val-Gly-Ser-Ile-Pro-Leu-Gly-Cys-Gly |
| CS13820 |
(Cys-Aca)-Bombesin (7-14)
|
序列
|
|
|
C52H81N15O11S2 |
1156.5 |
|
|
| Cys-Aca-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2 |
| CS13854 |
Cys(mPEG20K), Exendin-4 (9-39)
|
序列
|
|
|
|
~23369.96 |
|
|
| Cys(mPEG20K)-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 |
| CS13906 |
Linear form, Eptifibatide impurity
|
序列
|
|
|
C43H61O11S2N15 |
1028.1 |
|
|
| Mpr-(Homo-Arg)-Gly-Asp-Trp-Pro-Cys-NH2 (Linear form) |
| CS13946 |
ILP
|
序列
|
|
|
C178H303N65O54S |
4250 |
|
|
| Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Cys-Asp-Leu-Ala-Asp-Asn-Ile-Glu-Arg-Leu-Lys-Ala-Asn-Asp-Gly-Leu-Lys-Phe-Ser-Gln-Glu-Tyr-Glu-Ser-Ile-NH2 |
| CS15075 |
pHLIP Var3
|
序列
|
|
|
C152H225N35O44S |
3278.88 |
|
|
| Ala-Cys-Asp-Asp-Gln-Asn-Pro-Trp-Arg-Ala-Tyr-Leu-Asp-Leu-Leu-Phe-Pro-Thr-Asp-Thr-Leu-Leu-Leu-Asp-Leu-Leu-Trp-Gly |
沪公网安备 31011502005552号
沪ICP备13005633号-1